Health

XTL Biopharmaceuticals Announces ADS Ratio Change

March 20, 2026 16:10 ET  | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN, ISRAEL, March 20, 2026 (GLOBE NEWSWIRE) -- XTL…

3 months ago

IBA Launches myQAMatriXXAiR to Advance PatientSpecific QA in Particle Therapy

The first wireless ionization chamber array for particle therapy PSQA delivers fast, reliable verification for proton and carbon ion treatments,…

3 months ago

Financire de Tubize – Annual report 2025

Annual Report 2025Regulated information 21 March 2026 The board of directors of Financière de Tubize has established the 2025 annual…

3 months ago

Garaherb Claims Evaluated: Complete Scientific Investigation of Ingredients’ Effectiveness

Aurora, CO, March 20, 2026 (GLOBE NEWSWIRE) -- Editor's Note: The terms "Complete Scientific Investigation" and "Effectiveness" in the headline…

3 months ago

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

March 20, 2026 13:30 ET  | Source: SANUWAVE Health, Inc. EDEN PRAIRIE, Minn., March 20, 2026 (GLOBE NEWSWIRE) -- Sanuwave…

3 months ago

Disclosure of a transparency notification from Aberdeen Group plc

Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM CET Disclosure of a transparency notification from Aberdeen…

3 months ago

Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcytes 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate

March 18, 2026 19:34 ET  | Source: Vaxcyte, Inc. Based on the Strength of Unprecedented Results from the Positive Phase…

3 months ago

2026 MAP Awards presented to 20 organizations for high performance in revenue cycle

CHICAGO, March 18, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) announced the 2026 winners of the MAP…

3 months ago

VitalHub Reports Fourth Quarter 2025 Results

Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up 52% YoY to $31.4 millionAdjusted EBITDA⁽¹⁾ up 47%…

3 months ago